Zdrowie i gospodarka · 28/10/2022

FDA Draft Guidance for C. difficile Infection Treatment and Prevention

The Food and Drug Administration (FDA) has released a draft guidance for the pharmaceutical industry to aid in the development of treatments and prevention methods for Clostridioides difficile (C. difficile) infections, with the goal of reducing recurrence and improving patient outcomes.